DEL GATTO, ANNARITA
 Distribuzione geografica
Continente #
AS - Asia 1.602
NA - Nord America 1.109
EU - Europa 415
SA - Sud America 313
Continente sconosciuto - Info sul continente non disponibili 100
AF - Africa 21
OC - Oceania 1
Totale 3.561
Nazione #
US - Stati Uniti d'America 1.026
SG - Singapore 648
CN - Cina 405
BR - Brasile 244
VN - Vietnam 174
HK - Hong Kong 140
IT - Italia 136
FR - Francia 111
KR - Corea 76
CA - Canada 36
JP - Giappone 36
IN - India 32
GB - Regno Unito 31
DE - Germania 29
BD - Bangladesh 27
NL - Olanda 26
AR - Argentina 24
FI - Finlandia 22
CO - Colombia 15
MX - Messico 14
ID - Indonesia 12
IL - Israele 11
CR - Costa Rica 10
PL - Polonia 9
ZA - Sudafrica 9
SA - Arabia Saudita 8
ES - Italia 7
RU - Federazione Russa 7
VE - Venezuela 7
CL - Cile 6
EC - Ecuador 6
JM - Giamaica 6
PY - Paraguay 6
TR - Turchia 6
GR - Grecia 5
UA - Ucraina 5
AE - Emirati Arabi Uniti 4
KE - Kenya 4
NI - Nicaragua 4
NP - Nepal 4
PH - Filippine 4
CZ - Repubblica Ceca 3
HU - Ungheria 3
IQ - Iraq 3
SE - Svezia 3
AT - Austria 2
BO - Bolivia 2
BZ - Belize 2
EE - Estonia 2
GA - Gabon 2
GP - Guadalupe 2
IR - Iran 2
LT - Lituania 2
PE - Perù 2
PR - Porto Rico 2
PT - Portogallo 2
AG - Antigua e Barbuda 1
AU - Australia 1
AZ - Azerbaigian 1
BB - Barbados 1
BG - Bulgaria 1
BY - Bielorussia 1
CH - Svizzera 1
DK - Danimarca 1
DZ - Algeria 1
EG - Egitto 1
GD - Grenada 1
GT - Guatemala 1
HR - Croazia 1
IE - Irlanda 1
JO - Giordania 1
KH - Cambogia 1
MA - Marocco 1
MD - Moldavia 1
MF - Saint Martin 1
MK - Macedonia 1
MR - Mauritania 1
MY - Malesia 1
NO - Norvegia 1
OM - Oman 1
PK - Pakistan 1
PS - Palestinian Territory 1
RO - Romania 1
SC - Seychelles 1
SV - El Salvador 1
TH - Thailandia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 3.461
Città #
Singapore 377
Santa Clara 242
Hefei 158
San Jose 141
Hong Kong 140
Beijing 99
Lauterbourg 78
Ashburn 76
Seoul 76
Ho Chi Minh City 71
Dallas 46
Los Angeles 41
Naples 28
Hanoi 27
Tokyo 26
São Paulo 24
New York 19
Frankfurt am Main 16
Montreal 15
Rome 13
Afragola 12
Buffalo 12
Casandrino 12
Helsinki 12
Rio de Janeiro 12
Minamishinagawa 10
Philadelphia 10
Guangzhou 9
Lappeenranta 9
Atlanta 8
Chennai 8
Chicago 8
Council Bluffs 8
Phoenix 7
San José 7
Thái Bình 7
Warsaw 7
Amsterdam 6
Curitiba 6
Da Nang 6
Haikou 6
Haiphong 6
Manchester 6
Miami 6
Milan 6
The Bronx 6
Athens 5
Belo Horizonte 5
Bengaluru 5
Bogotá 5
Boston 5
Brooklyn 5
Charlotte 5
Cincinnati 5
Guarulhos 5
Hải Dương 5
Jeddah 5
Nuremberg 5
Orem 5
Porto Alegre 5
Salvador 5
Ankara 4
Baltimore 4
Brasília 4
Can Tho 4
Denver 4
Ercolano 4
Houston 4
Managua 4
Nairobi 4
Pittsburgh 4
Poplar 4
Quận Một 4
Toronto 4
Turin 4
Aracaju 3
Auburn 3
Biên Hòa 3
Caxias do Sul 3
Dayton 3
Dhaka 3
Düsseldorf 3
Elk Grove Village 3
Fortaleza 3
Guayaquil 3
Guwahati 3
Jackson 3
Johannesburg 3
Juiz de Fora 3
Kathmandu 3
London 3
Manaus 3
Marília 3
Mexico City 3
Munich 3
Osasco 3
Prague 3
Riyadh 3
San Juan 3
Shanghai 3
Totale 2.131
Nome #
18FLUORO-ACTIVE PEPITDES.: OPTIMIZATION OF RADIOLABELLING SYNTHESIS 86
Therapeutic Potential of a Novel alpha(v)beta(3) Antagonist to Hamper the Aggressiveness of Mesenchymal Triple Negative Breast Cancer Sub-Type 85
Peptoids: Smart and Emerging Candidates for the Diagnosis of Cancer, Neurological and Autoimmune Disorders 83
Gold-Speckled SPION@SiO2 Nanoparticles Decorated with Thiocarbohydrates for ASGPR1 Targeting: Towards HCC Dual Mode Imaging Potential Applications 83
Molecular interactions between a diphenyl scaffold and PED/PEA15: Implications for type II diabetes therapeutics targeting PED/PEA15 - Phospholipase D1 interaction 77
Conformational studies of RGDechi peptide by natural-abundance NMR spectroscopy 73
NIR Emitting Nanoprobes Based on Cyclic RGD Motif Conjugated PbS Quantum Dots for Integrin-Targeted Optical Bioimaging 73
A new cryptic host defense peptide identified in human 11-hydroxysteroid dehydrogenase-1 ?-like: from in silico identification to experimental evidence 72
[99mTc][Tc(N)PNP43]-Labeled RGD Peptides As New Probes for a Selective Detection of alpha v beta (3) Integrin: Synthesis, Structure-Activity and Pharmacokinetic Studies. 67
A multi-targeting approach to fight sars-cov-2 attachment 65
An overview of peptide-based molecules as potential drug candidates for multiple sclerosis 63
Investigation of the Best Conditions to Obtain c(RGDfK) Peptide on Solid Phase 62
Editorial: Peptidomimetics: Synthetic Tools for Drug Discovery and Development 61
High-Resolution Conformational Analysis of RGDechi-Derived Peptides Based on a Combination of NMR Spectroscopy and MD Simulations 61
Peptides Targeting Angiogenesis Related Growth Factor Receptors 60
A novel approach for studying receptor-ligand interactions on living cells surface by using NUS/T1ρ-NMR methodologies combined with computational techniques: The RGDechi15D-αvβ5 integrin complex 60
A selective ?v?5 integrin antagonist hidden into the anophelin family protein cE5 from the malaria vector anopheles gambiae 60
Selective Detection of alfa_v beta_3 Integrin Receptors Using [99mTc(N)PNP]-labelled RGDechi Peptides 60
New and selective radiolabeled alpha(v)beta(3) antagonist as tracer in tumor diagnosis 59
Imaging of alpha(v)beta(3) integrin expression with a 18F-labeled RGD peptide and microPET 58
Morphological, productive and energetic characterization of Brassica carinata in Central, North and South Areas of Italy 51
Gold Nanoparticles Capped by a GC-Containing Peptide Functionalized with an RGD Motif for Integrin Targeting. 51
Structural Zn(II) Implies a Switch from Fully Cooperative to Partly Downhill Folding in Highly Homologous Proteins 51
Screening a Molecular Fragment Library to Modulate the PED/PEA15-Phospholipase D1 Interaction in Cellular Lysate Environments 50
In vitro activity of the avb3 integrin antagonist RGDechi-hCit on malignant melanoma cells 49
Selective Targeting of alphavbeta5 Integrin in HepG2 Cell Line by RGDechi15D Peptide 49
On-Bead Peptoid Dimerization Induced by Incorporation of Glycosylated Bridging Units in Submonomer Solid-Phase Approach to Glycopeptoids 48
18FLUORO-ACTIVE-PEPTIDES: OPTIMIZATION OF RADIOLABELLING SYNTHESIS 48
Evaluation of the anti-angiogenic properties of the new selective alpha(V)beta(3) integrin antagonist RGDechiHCit 46
Bioinspired RGD-Functionalized Gold Nanoparticles for Integrin-Driven Interaction with Melanoma Cells 46
Chemical Modification for Proteolytic Stabilization of the Selective alpha(v)beta(3) Integrin RGDechi Peptide: in Vitro and in Vivo Activities on Malignant Melanoma Cells 45
LC-MS and MALDI-TOF supported metabolism studies of the selective ?v?3 RGDechi peptide and of thecorresponding [99mTc(N)PNP]-tagged derivatives. 44
Conjugated Platinum(II)-peptide complexes for targeting integrin receptors 43
Structure-Based Design of a Potent Artificial Transactivation Domain Based on p53 43
IN VIVO IMAGING OF ALPHA(V)BETA(3) INTEGRIN EXPRESSION WITH A RADIOLABELED CHIMERIC RDG PEPTIDE 41
HIGH YIELD HPLC PURIFICATION OF 18F-RDG-ECHI FOR INJECTION INTO MICE. 40
Integrin-targeting with peptide-bioconjugated semiconductor-magnetic nanocrystalline heterostructures 38
Imaging of alpha(v)beta(3) Expression by a Bifunctional Chimeric RGD Peptide not Cross-Reacting with alpha(v)beta(5) 37
Characterization of a Designed Vascular Endothelial Growth Factor Receptor Antagonist Helical Peptide with Antiangiogenic Activity in Vivo 37
In vitro activity of the alfavbeta3 integrin antagonist RGDechi-hCit on malignant melanoma cells. 37
Design, synthesis and evaluation of gluten peptide analogues as inhibitors of the HLA/DQ8-mediated celiac immune response 37
Silver nanoparticles functionalized with a fluorescent cyclic RGD peptide: a versatile integrin targeting platform for cells and bacteria 36
Peptides reproducing the ApoA-I 141-164 region: Studies on Hpt recognition 35
Novel and selective αvβ3 receptor peptide antagonist: Design, synthesis, and biological behavior 35
Insights into the anticancer properties of the first antimicrobial peptide from Archaea 34
AN IMPROVED RADIOLABELING SYNTHESIS OF RGDECHI WITH 18F-FLUORIDE. 33
In vivo imaging of alpha(v)beta(3) integrin expression with a radiolabeled chimeric RGD peptide 33
Imaging of alpha(v)beta(3) integrin expression with a 18F-labeled RGD peptide and microPET 33
MicroPET/CT of mice bearing alpha(v)beta(3)-expressing tumors by a 18F-labeled bifunctional chimeric RGD peptide 32
P53/TFIIH complex: structure-guided design of peptides to modulate apoptosis mediated by p53-dependent pathways 32
Targeting avb3 integrin receptor by a new and selective peptide antagonist for tumour imaging and radionuclide therapy 32
A new and selective radiolabeled áVâ3 peptide antagonist as tracer in tumor diagnosis 32
A RADIOLABELING SYNTHESIS OF RGD ECHI WITH 18FLUORIDE- 31
A New and selective radiolabeled alphavbeta3 peptide antagonist as tracer in tumor diagnosis 31
Zinc to Cadmium Replacement in the A. thaliana SUPERMAN Cys(2)His(2) Zinc Finger Induces Structural Rearrangements of Typical DNA Base Determinant Positions. 31
Novel and selective alpha(v)beta3 receptor peptide antagonist: design, synthesis, and biological behavior. 31
BIOMEDICAL NANOTECHNOLOGY: PREPARATION AND CHARACTERIZATION OF NEW FUNCTIONALIZED GOLD NANOPARTICLES 30
IMAGING IN VIVO DELL'ESPESSIONE DELL'INTEGRINA alfa(v)beta(3) CON UN PEPTIDE CHIMERICO RGD RADIOMARCATO 30
A NEW AND SELECTIVE RADIOLABELED ALPHAVBETA3 PEPTIDE ANTAGONIST AS TRACER IN TUMOR DIAGNOSIS. 30
Engineering peptides in angiogenesis 30
Selective avb3 receptor peptide antagonist for therapeutic and diagnostic applications 30
Development Of Peptides Able To Modulate The Interaction Of AKAP121 With Mitochondria 29
ASSESSMENT OF THE IN VITRO ACTIVITY OF RGDECHI-HCIT, alpha V beta3 INTEGRIN ANTAGONIST, ON MALIGNANT MELANOMA CELLS 28
Helical peptide as VEGF antagonist 28
Peptide-based molecules in angiogenesis. 28
Proangiogenic properties of QK, a peptide mimicking VEGF/KDR binding interface 28
Novel and selective alpha v beta 3 receptor peptide antagonist: Design, synthesis and biological behaviour 28
Deciphering rgdechi peptide??5?1integrin interaction mode in isolated cell membranes 27
Targeting avb3 integrin receptor by a new and selective peptide antagonist 27
Small helical peptides as modulator of angiogenesis 27
New and selective radiolabeled alphavbeta3 peptide antagonist as tracer in tumor diagnosis 26
Novel and Selective Ligand of the Integrin n Ñv Ò3 Receptor: Design, Synthesis and Biological Behaviour 26
Structure-based design of short peptides and samll molecules that compete with P53 for binding to TFIIH 26
RGDechi-hCit: alpha v beta 3 Selective Pro-Apoptotic Peptide as Potential Carrier for Drug Delivery into Melanoma Metastatic Cells 26
Integrin receptor family: promising target for therapeutic and diagnostic applications 25
Inibizione dell angiogenesi mediante un antagonista selettivo dell integrina ±V²3 endoteliale: studi in vitro e in vivo 25
BIOMEDICAL NANOTECHNOLOGY: PREPARATION AND CHARACTERIZATION OF NEW FUNCTIONALIZED GOLD NANOPARTICLES 24
Preparation and Characterization of new functionalized gold nanoparticles 24
Development of new molecules that compete with p53 for Binding to TFIIH 23
SYNTHETIC PEPTIDES ABLE TO MODULATE THE INTERACTION OF AKAP121 WITH MITOCHONDRIA 23
Peptides for tumour therapy and diagnosis: current status and future directions 22
AKAP121 downregulation impairs protective cAMP signals, promotes mitochondrial dysfunction, and increases oxidative stress 22
Small helical peptides as modulator of angiogenesis 22
A Combined NMR and Computational Approach to Determine the RGDechi-hCit-alpha(v)beta(3) Integrin Recognition Mode in Isolated Cell Membranes 21
A NEW AND SELECTIVE RADIOLABELLED v 3 PEPTIDE ANTAGONIST AS TRACER IN TUMOR DIAGNOSIS 18
Gold- and Platinum-Peptide Bioconjugates in Cancer Therapy: Recent Advances and Future Directions 11
Identification of the first peptide inhibitor of UBE2C enzymatic activity: insights from metadynamics-guided folding and binding studies 7
Totale 3.561
Categoria #
all - tutte 12.765
article - articoli 8.110
book - libri 112
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.987


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202448 0 0 0 0 0 0 0 0 11 4 24 9
2024/20251.163 4 5 124 48 226 24 33 57 41 48 309 244
2025/20261.907 116 232 163 333 361 68 261 86 87 121 42 37
2026/2027443 112 84 247 0 0 0 0 0 0 0 0 0
Totale 3.561